Neuronetics (STIM) Liabilities and Shareholders Equity (2017 - 2026)

Neuronetics (STIM) has 10 years of Liabilities and Shareholders Equity data on file, last reported at $125.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 11.65% year-over-year to $125.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $547.1 million (up 20.56% YoY) and the FY2025 annual result came in at $141.6 million, changed 0.46% from the prior year.
• Liabilities and Shareholders Equity retreated to $125.4 million in Q1 2026 per STIM's latest filing, from $141.6 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $145.5 million in Q3 2025 and bottomed at $74.1 million in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $119.2 million (2022), against an average of $118.0 million.
• The widest annual swing landed in 2023, when Liabilities and Shareholders Equity fell 22.01%; it then surged 96.26% in 2025.
• Tracing STIM's Liabilities and Shareholders Equity over 5 years: stood at $116.9 million in 2022, then fell by 0.9% to $115.8 million in 2023, then rose by 21.65% to $140.9 million in 2024, then grew by 0.46% to $141.6 million in 2025, then declined by 11.38% to $125.4 million in 2026.
• Per Business Quant, the three latest STIM Liabilities and Shareholders Equity figures stand at $125.4 million (Q1 2026), $141.6 million (Q4 2025), and $145.5 million (Q3 2025).

Peer Comparison